Skip to main content
Top
Published in: Diabetology International 1/2022

01-01-2022 | Care | Original Article

Tailored notification encouraging examinees with abnormal glucose levels in health checkups to seek medical care

Authors: Miki Nagafuchi, Hirokazu Takahashi, Keizo Anzai, Miki Hidaka, Tsuyoshi Matsushita, Kimie Fujita

Published in: Diabetology International | Issue 1/2022

Login to get access

Abstract

The aims of this study were to generate a written notification message using social marketing methods to encourage examinees with abnormal glucose levels to seek medical care and to evaluate the optimized message. A semi-structured interview was conducted among examinees with abnormal glucose levels who had never visited a medical clinic for diagnosis of hyperglycemia. Patients were divided into two segments. A tailored notification letter was developed according to these segments using a social marketing approach. Other examinees were prospectively enrolled as the control group. The tailored notification for Segment 1 included a web code to access a health care provider. Future loss of time and money was emphasized in the message for Segment 2. According to responses in a telephone interview, 654 examinees with abnormal fasting glucose levels in a health checkup were divided into Group 1 (n = 178), Group 2 (n = 24), and a control group (n = 452) and given a tailored or conventional notification letter. The proportion of examinees who actually visited a health care provider in Group 1 (20.8%) was significantly higher than that in the control group (11.1%); no examinees in Group 2 visited a health care provider. Receipt of a tailored notification was a significant factor associated with visiting a health care provider, independent of age, sex, or severity of glucose abnormality (odds ratio 1.77; p = 0.02). Our results showed that tailored notification developed using a social marketing approach prompted health checkup examinees with abnormal glucose levels to seek medical care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Saeedi P, Petersohn I, Salpea P, et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:1–9 (107843). Saeedi P, Petersohn I, Salpea P, et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:1–9 (107843).
2.
go back to reference NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980 a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;2016(387):1513–30. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980 a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;2016(387):1513–30.
3.
go back to reference Gakidou E, Mallinger L, Abbott-Klafter J, et al. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ. 2011;89:172–83.CrossRef Gakidou E, Mallinger L, Abbott-Klafter J, et al. Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ. 2011;89:172–83.CrossRef
5.
go back to reference Goto E, Ishikawa H, Okuhara T, Kato M, Okada M, Kiuchi T. Factors associated with adherence to recommendations to visit a physician after annual health checkups among Japanese employees: a cross-sectional observational study. Ind Health. 2018;56:155–9.CrossRef Goto E, Ishikawa H, Okuhara T, Kato M, Okada M, Kiuchi T. Factors associated with adherence to recommendations to visit a physician after annual health checkups among Japanese employees: a cross-sectional observational study. Ind Health. 2018;56:155–9.CrossRef
6.
go back to reference Kotler P, Lee NR. Up and out of poverty: the social marketing solution—a toolkit for policy markers. Entrepreneurs, NGOs, companies, and governments. London: Pearson Education. Inc; 2009. (Japanese version). Kotler P, Lee NR. Up and out of poverty: the social marketing solution—a toolkit for policy markers. Entrepreneurs, NGOs, companies, and governments. London: Pearson Education. Inc; 2009. (Japanese version).
8.
go back to reference Gordon R, McDermott L, Stead M, Angus K. The effectiveness of social marketing interventions for health improvement: what’s the evidence? Public Health. 2006;120:1133–9.CrossRef Gordon R, McDermott L, Stead M, Angus K. The effectiveness of social marketing interventions for health improvement: what’s the evidence? Public Health. 2006;120:1133–9.CrossRef
9.
go back to reference Aceves-Martins M, Llauradó E, Tarro L, et al. Effectiveness of social marketing strategies to reduce youth obesity in European school-based interventions: a systematic review and meta-analysis. Nutr Rev. 2016;74:337–51.CrossRef Aceves-Martins M, Llauradó E, Tarro L, et al. Effectiveness of social marketing strategies to reduce youth obesity in European school-based interventions: a systematic review and meta-analysis. Nutr Rev. 2016;74:337–51.CrossRef
10.
go back to reference Dietrich T, Rundle-Thiele S, Schuster L, et al. Differential segmentation responses to an alcohol social marketing program. Addict Behav. 2015;49:68–77.CrossRef Dietrich T, Rundle-Thiele S, Schuster L, et al. Differential segmentation responses to an alcohol social marketing program. Addict Behav. 2015;49:68–77.CrossRef
11.
go back to reference Kavin M, Añel-Tiangco RM, Mauger DT, Gabbay RA. Development and pilot of a low-literacy diabetes education book using social marketing techniques. Diabetes Ther. 2010;1:93–102.CrossRef Kavin M, Añel-Tiangco RM, Mauger DT, Gabbay RA. Development and pilot of a low-literacy diabetes education book using social marketing techniques. Diabetes Ther. 2010;1:93–102.CrossRef
12.
go back to reference Hirai K, Ishikawa Y, Fukuyoshi J, et al. Tailored message interventions versus typical messages for increasing participation in colorectal cancer screening among a non-adherent population: a randomized controlled trial. BMC Public Health. 2016;16:1–8.CrossRef Hirai K, Ishikawa Y, Fukuyoshi J, et al. Tailored message interventions versus typical messages for increasing participation in colorectal cancer screening among a non-adherent population: a randomized controlled trial. BMC Public Health. 2016;16:1–8.CrossRef
13.
go back to reference Harada K, Hirai K, Arai H, et al. Worry and intention among Japanese women: implications for an audience segmentation strategy to promote mammography adoption. Health Commun. 2013;28:709–17.CrossRef Harada K, Hirai K, Arai H, et al. Worry and intention among Japanese women: implications for an audience segmentation strategy to promote mammography adoption. Health Commun. 2013;28:709–17.CrossRef
14.
go back to reference Fishbein M. A reasoned action approach to health promotion. Med Decis Making. 2008;28:834–44.CrossRef Fishbein M. A reasoned action approach to health promotion. Med Decis Making. 2008;28:834–44.CrossRef
15.
go back to reference Hamanosono M, Araki Y, Shimohara Y, Fukushima N, Sakata K, Suga M. Analysis of determining factors in motivating follow-up subjects to undergo further examinations. Ningen Dock. 2014;29:496–502 (in Japanese). Hamanosono M, Araki Y, Shimohara Y, Fukushima N, Sakata K, Suga M. Analysis of determining factors in motivating follow-up subjects to undergo further examinations. Ningen Dock. 2014;29:496–502 (in Japanese).
16.
go back to reference Thaler RH, Sunstein CR. Nudge—improving decisions about health, wealth and happiness. Penguin Books; 2009. Thaler RH, Sunstein CR. Nudge—improving decisions about health, wealth and happiness. Penguin Books; 2009.
17.
go back to reference Möllenkamp M, Zeppernick M, Schreyögg J. The effectiveness of nudges in improving the self-management of patients with chronic diseases: a systematic literature review. Health Policy. 2019;123:1199–209.CrossRef Möllenkamp M, Zeppernick M, Schreyögg J. The effectiveness of nudges in improving the self-management of patients with chronic diseases: a systematic literature review. Health Policy. 2019;123:1199–209.CrossRef
18.
go back to reference Velema E, Vyth EL, Hoekstra T, Steenhuis IHM. Nudging and social marketing techniques encourage employees to make healthier food choices: a randomized controlled trial in 30 worksite cafeterias in The Netherlands. Am J Clin Nutr. 2018;107:236–46.CrossRef Velema E, Vyth EL, Hoekstra T, Steenhuis IHM. Nudging and social marketing techniques encourage employees to make healthier food choices: a randomized controlled trial in 30 worksite cafeterias in The Netherlands. Am J Clin Nutr. 2018;107:236–46.CrossRef
19.
go back to reference Misawa D, Fukuyoshi J, Sengoku S. Cancer prevention using machine learning, nudge theory and social impact bond. Int J Environ Res Public Health. 2020;17:1–11.CrossRef Misawa D, Fukuyoshi J, Sengoku S. Cancer prevention using machine learning, nudge theory and social impact bond. Int J Environ Res Public Health. 2020;17:1–11.CrossRef
20.
go back to reference Andreasen AR. Marketing social marketing in the social change marketplace. J Public Policy. 2002;21:3–13. Andreasen AR. Marketing social marketing in the social change marketplace. J Public Policy. 2002;21:3–13.
21.
go back to reference Grier S, Bryant CA. Social marketing in public health. Annu Rev Public Health. 2005;26:319–39.CrossRef Grier S, Bryant CA. Social marketing in public health. Annu Rev Public Health. 2005;26:319–39.CrossRef
22.
go back to reference Goto K, Miwa I. Examination of approaches to improve the examination rate after recommending examinations for people suspected of having diabetes. J Japan Pharm Commun Soc. 2016;14:14–22 (in Japanese). Goto K, Miwa I. Examination of approaches to improve the examination rate after recommending examinations for people suspected of having diabetes. J Japan Pharm Commun Soc. 2016;14:14–22 (in Japanese).
23.
go back to reference Okudaira M, Uchigata Y, Okada T, Iwamoto Y. Influence of health checkup and previous intermittent treatment on diabetic complications. J Japan Diabetes Soc. 2003;46:781–5 (in Japanese). Okudaira M, Uchigata Y, Okada T, Iwamoto Y. Influence of health checkup and previous intermittent treatment on diabetic complications. J Japan Diabetes Soc. 2003;46:781–5 (in Japanese).
25.
go back to reference Okada M, Oeda S, Katsuki N, et al. Recommendations from primary care physicians, family, friends, and work colleagues influence patients’ decisions related to hepatitis screening, medical examinations and antiviral treatment. Exp Ther Med. 2020;29:73–82. Okada M, Oeda S, Katsuki N, et al. Recommendations from primary care physicians, family, friends, and work colleagues influence patients’ decisions related to hepatitis screening, medical examinations and antiviral treatment. Exp Ther Med. 2020;29:73–82.
Metadata
Title
Tailored notification encouraging examinees with abnormal glucose levels in health checkups to seek medical care
Authors
Miki Nagafuchi
Hirokazu Takahashi
Keizo Anzai
Miki Hidaka
Tsuyoshi Matsushita
Kimie Fujita
Publication date
01-01-2022
Publisher
Springer Singapore
Keyword
Care
Published in
Diabetology International / Issue 1/2022
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-021-00534-1

Other articles of this Issue 1/2022

Diabetology International 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine